Oramed Pharmaceuticals Inc.

Historical 13F Holders

Symbol
ORMP
CUSIP
68403P203
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 68403P203 since 12/18/2024, largest first.

Filer % of Class Filed
Nadav Kidron 13D/A 7.6% 8/28/2025
Event 2/11/2025
Aquamarine Financial (Cayman) Ltd 13G/A 6.4% 11/13/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
BML Investment Partners, L.P. 13G/A
2.5% 6/29/2026
Event 6/26/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 66 12.7 M $59.1M
2026 Q2 84 16.8 M $80.7M
2026 Q1 64 13.2 M $45.0M
2025 Q4 57 13.1 M $37.2M
2025 Q3 47 9.21 M $24.3M
2025 Q2 48 7.25 M $16.3M
2025 Q1 53 7.77 M $16.6M
2024 Q4 56 7.67 M $18.6M
2024 Q3 55 6.96 M $17.0M
2024 Q2 59 5.93 M $15.2M
2024 Q1 52 5.26 M $15.4M
2023 Q4 56 5.16 M $11.9M
2023 Q3 57 2.30 M $5.99M
2023 Q2 52 2.28 M $8.15M
2023 Q1 62 4.26 M $9.30M
2022 Q4 77 3.60 M $43.2M
2022 Q3 71 3.94 M $25.5M
2022 Q2 89 6.69 M $31.0M
2022 Q1 104 9.05 M $78.4M
2021 Q4 119 8.58 M $122M
2021 Q3 95 5.41 M $119M
2021 Q2 77 3.84 M $51.4M
2021 Q1 46 1.24 M $64.2M
2020 Q4 43 1.46 M $6.19M
2020 Q3 37 2.00 M $5.19M
2020 Q2 38 1.35 M $4.73M
2020 Q1 34 636 k $1.96M
2019 Q4 32 624 k $3.22M
2019 Q3 31 760 k $2.43M
2019 Q2 27 839 k $3.01M
2019 Q1 26 1.07 M $3.91M
2018 Q4 29 1.90 M $5.76M
2018 Q3 29 1.76 M $8.56M
2018 Q2 21 281 k $2.09M
2018 Q1 21 276 k $1.85M
2017 Q4 27 378 k $3.40M
2017 Q3 22 276 k $2.73M
2017 Q2 23 180 k $1.35M
2017 Q1 21 149 k $915k
2016 Q4 24 139 k $850k
2016 Q3 22 182 k $1.32M
2016 Q2 26 221 k $1.84M
2016 Q1 26 201 k $1.32M
2015 Q4 27 210 k $1.78M
2015 Q3 19 157 k $855k
2015 Q2 17 335 k $1.91M
2015 Q1 18 544 k $3.37M
2014 Q4 22 1.00 M $5.61M
2014 Q3 19 1.38 M $11.1M
2014 Q2 22 1.43 M $13.7M
2014 Q1 23 1.31 M $15.3M